Try

Chugai Pharmaceutical Co., Ltd.

4519.TJapan

40 filed reports · 370 financial concepts · 0 earnings calls · 0 media appearances

Filed reports

40 reports · Sep 2016 to Jun 2026

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Q1 · quarterly securities reportEDINET8936Mar 2017 to Mar 2024
Q3 · quarterly securities reportEDINET8984Sep 2016 to Sep 2023
Half Year · quarterly securities reportEDINET7890Jun 2017 to Jun 2023
Annual · amended annual securities reportEDINET61,498Dec 2017 to Dec 2023
Annual · annual securities reportEDINET41,275Dec 2016 to Dec 2025
Half Year · half-year securities reportEDINET3545Jun 2024 to Jun 2026
Q1 · quarterly earnings release (kessan tanshin)EDINET2237Mar 2025 to Mar 2026
Q3 · quarterly earnings release (kessan tanshin)EDINET2238Sep 2024 to Sep 2025

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 H1half-year securities reportJun 30, 2026Jul 27, 2026234Open
FY2026 Q1quarterly earnings release (kessan tanshin)Mar 31, 2026Apr 24, 2026181Open
FY2025annual securities reportDec 31, 2025Mar 25, 2026543Open
FY2025 Q3quarterly earnings release (kessan tanshin)Sep 30, 2025Oct 24, 2025182Open
FY2025 H1half-year securities reportJun 30, 2025Jul 25, 2025156Open
FY2025 Q1quarterly earnings release (kessan tanshin)Mar 31, 2025Apr 24, 202556Open
FY2024annual securities reportDec 31, 2024Mar 27, 2025287Open
FY2024 Q3quarterly earnings release (kessan tanshin)Sep 30, 2024Oct 25, 202456Open
FY2024 H1half-year securities reportJun 30, 2024Jul 26, 2024155Open
FY2024 Q1quarterly securities reportMar 31, 2024Apr 25, 2024227Open
FY2023amended annual securities reportDec 31, 2023Jul 26, 2024346Open
FY2023 Q3quarterly securities reportSep 30, 2023Oct 25, 2023290Open

Financial data

370 concepts · 6,603 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

IFRS206 concepts · 5,234 facts · Sep 2015 to Jun 2026

  • EPS (Basic)87 · Sep 2015 to Jun 2026
  • Net Income87 · Sep 2015 to Jun 2026
  • Revenue87 · Sep 2015 to Jun 2026
  • Comprehensive Income Attributable to Owners of Parent80 · Sep 2015 to Jun 2026
  • EPS (Diluted)80 · Sep 2015 to Jun 2026
  • Pretax Income80 · Sep 2015 to Jun 2026
  • Profit Attributable to Owners of Parent80 · Sep 2015 to Jun 2026
  • Total Comprehensive Income80 · Sep 2015 to Jun 2026
  • Cash and Equivalents74 · Sep 2015 to Jun 2026
  • Total Assets74 · Sep 2015 to Jun 2026
  • Financing Cash Flow70 · Sep 2015 to Jun 2026
  • Investing Cash Flow70 · Sep 2015 to Jun 2026
  • Operating Cash Flow70 · Sep 2015 to Jun 2026
  • Ratio of owners' equity to gross assets (IFRS), Key financial data66 · Sep 2015 to Jun 2026
  • Stockholders Equity55 · Dec 2017 to Jun 2026
  • Total equity49 · Sep 2016 to Jun 2026
  • Deferred tax assets (IFRS)48 · Dec 2018 to Jun 2026
  • Deferred tax liabilities (IFRS)48 · Dec 2018 to Jun 2026
  • Equity Attributable to Owners of Parent48 · Dec 2018 to Jun 2026
  • Income taxes payable - CL (IFRS)48 · Dec 2018 to Jun 2026
  • Intangible assets (IFRS)48 · Dec 2018 to Jun 2026
  • Inventory48 · Dec 2018 to Jun 2026
  • Other current assets - CA (IFRS)48 · Dec 2018 to Jun 2026
  • Other current liabilities - CL (IFRS)48 · Dec 2018 to Jun 2026

GAAP164 concepts · 1,369 facts · Dec 2015 to Dec 2025

  • Accounts payable - other11 · Dec 2015 to Dec 2025
  • Accounts payable - trade11 · Dec 2015 to Dec 2025
  • Accounts receivable - other11 · Dec 2015 to Dec 2025
  • Accounts receivable - trade11 · Dec 2015 to Dec 2025
  • Accrued expenses11 · Dec 2015 to Dec 2025
  • Allowance for doubtful accounts-IOA-by group11 · Dec 2015 to Dec 2025
  • Asset retirement obligations-NCL11 · Dec 2015 to Dec 2025
  • Buildings, net11 · Dec 2015 to Dec 2025
  • Capital surplus11 · Dec 2015 to Dec 2025
  • Cash and deposits11 · Dec 2015 to Dec 2025
  • Construction in progress11 · Dec 2015 to Dec 2025
  • Cost of Revenue11 · Dec 2015 to Dec 2025
  • Deferred gains or losses on hedges11 · Dec 2015 to Dec 2025
  • Deposits received11 · Dec 2015 to Dec 2025
  • Disposal of treasury shares11 · Dec 2015 to Dec 2025
  • Dividend paid per share11 · Dec 2015 to Dec 2025
  • Dividends of surplus11 · Dec 2015 to Dec 2025
  • EPS (Basic)11 · Dec 2015 to Dec 2025
  • EPS (Diluted)11 · Dec 2015 to Dec 2025
  • Equity-to-asset ratio, Key financial data11 · Dec 2015 to Dec 2025
  • Extraordinary income11 · Dec 2015 to Dec 2025
  • Extraordinary losses11 · Dec 2015 to Dec 2025
  • Gain on sale of non-current assets - EI11 · Dec 2015 to Dec 2025
  • General reserve11 · Dec 2015 to Dec 2025

Segments

Figures broken down by business line, region, product or another axis the company reports on.

No segment breakdowns.

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

Transcripts with management claims and analyst questions, one per fiscal period.

No earnings-call transcripts for this company.

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.

Chugai Pharmaceutical Co., Ltd. (4519.T) data · FactIQ